The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Clinical translation of FLASH radiotherapy: Why and how?
Abstract
Over the past decades, technological advances have transformed radiation therapy (RT) into a precise and powerful treatment for cancer patients. Nevertheless, the treatment of radiation-resistant tumors is still restricted by the dose-limiting normal tissue complications. In this context, FLASH-RT is emerging in the field. Consisting of delivering doses within an extremely short irradiation time, FLASH-RT has been identified as a promising new tool to enhance the differential effect between tumors and normal tissues. Indeed, preclinical studies on various animal models and a veterinarian clinical trial have recently shown that compared to conventional dose-rate RT, FLASH-RT could control tumors while minimizing normal tissue toxicity. In the present review, we summarize the main data supporting the clinical translation of FLASH-RT and explore its feasibility, the key irradiation parameters and the potential technologies needed for a successful clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., Miles, E. A., Miah, A. B., Newbold, K., Tanay, M., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70290-4 · Cited by 1,706
Favaudon, V., Caplier, L., Monceau, V., Pouzoulet, F., Sayarath, M., Fouillade, C., Poupon, M.-F., Brito, I., Hupé, P., Bourhis, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008973 · Cited by 1,476
Self-citationHyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
Bourhis, J., Overgaard, J., Audry, H., Ang, K. K., Saunders, M., Bernier, J., Horiot, J.-C., Le Maître, A., Pajak, T. F., Poulsen, M. G., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69121-6 · Cited by 1,085
Self-citationMontay-Gruel, P., Petersson, K., Jaccard, M., Boivin, G., Germond, J.-F., Petit, B., Doenlen, R., Favaudon, V., Bochud, F., Bailat, C., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.05.003 · Cited by 692
Self-citationLong-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species
Montay-Gruel, P., Acharya, M. M., Petersson, K., Alikhani, L., Yakkala, C., Allen, B. D., Ollivier, J., Petit, B., Jorge, P. G., Syage, A. R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901777116 · Cited by 599
Self-citationMontay-Gruel, P., Bouchet, A., Jaccard, M., Patin, D., Serduc, R., Aim, W., Petersson, K., Petit, B., Bailat, C., Bourhis, J., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.08.016 · Cited by 405
Self-citationDe Ruysscher, D., Faivre-Finn, C., Nestle, U., Hurkmans, C. W., Le Péchoux, C., Price, A., & Senan, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.3271 · Cited by 364
Biological effects in normal cells exposed to FLASH dose rate protons
Buonanno, M., Grilj, V., & Brenner, D. J. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.02.009 · Cited by 306
Experimental Set-up for FLASH Proton Irradiation of Small Animals Using a Clinical System
Patriarca, A., Fouillade, C., Auger, M., Martin, F., Pouzoulet, F., Nauraye, C., Heinrich, S., Favaudon, V., Meyroneinc, S., Dendale, R., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.06.403 · Cited by 284
Barendsen, G. W., Koot, C. J., van Kersen, G. R., Bewley, D. K., Field, S. B., & Parnell, C. J. (1966) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553006614550421 · Cited by 259
Ultrahigh Dose-rate Radiotherapy: Next Steps for FLASH-RT
Harrington, K. J. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1796 · Cited by 88
Bourhis, J., Blanchard, P., Maillard, E., Brizel, D. M., Movsas, B., Büntzel, J., Langendijk, J. A., Komaki, R. U., Leong, S. S., Levendag, P. C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.1454 · Cited by 55
Self-citation
Cited by
Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species
Montay-Gruel, P., Acharya, M. M., Petersson, K., Alikhani, L., Yakkala, C., Allen, B. D., Ollivier, J., Petit, B., Jorge, P. G., Syage, A. R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901777116 · Cited by 599
Self-citationBiological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken
Vozenin, M.-C., Hendry, J. H., & Limoli, C. L. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.04.001 · Cited by 484
Self-citationUltra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
Wilson, J. D., Hammond, E. M., Higgins, G. S., & Petersson, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01563 · Cited by 473
Towards clinical translation of FLASH radiotherapy
Vozenin, M.-C., Bourhis, J., & Durante, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00697-z · Cited by 363
Self-citationPhysics and biology of ultrahigh dose-rate (FLASH) radiotherapy: a topical review
Esplen, N., Mendonca, M. S., & Bazalova-Carter, M. (2020) · Physics in Medicine & Biology · doi:10.1088/1361-6560/abaa28 · Cited by 270
Metadata
- Authors
- Bourhis, J., Montay-Gruel, P., Gonçalves Jorge, P., Bailat, C., Petit, B., Ollivier, J., Jeanneret-Sozzi, W., Ozsahin, M., Bochud, F., Moeckli, R., Germond, J.-F., & Vozenin, M.-C.
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 139
- Pages
- 11-17
- ISSN
- 0167-8140 (ISSN-L)
- OpenAlex
- W2955197368
- Cited by
- 474
- References
- 12
- FWCI
- 47.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.